Intervet/Schering-Plough Animal Health in early March delivered 12 million doses of its foot-and-mouth disease (FMD) vaccine to South Korea in an effort to halt the country’s FMD outbreak.
The South Korean government reported the FMD outbreak in November 2010. Since then, more than three million pigs, cattle, goats and deer have been culled.
The South Korean Ministry for Food, Agriculture, Forestry and Fisheries has since started vaccinating all 13 million livestock in the country after initial measures were not effective in controlling the outbreak.
It is anticipated that the ongoing vaccination campaign will soon show results in the control of the outbreak in concert with the other measures applied, according to Intervet/Schering-Plough Animal Health, a subsidiary of Merck & Co. Inc. of Whitehouse Station, N.J.
The 12 million doses of Decivac FMD DOE, an inactivated oil-adjuvanted vaccine, were produced at the company’s production facility in Germany.